Engimmune Therapeutics strikes ‘fast-forward’ micro-fluidics collaboration with Swiss innovator CSEM

Collaboration with CSEM will speed up identification of suitable soluble TCR candidates Engimmune’s executive team will be presenting at Biotech Showcase in San Francisco in January BASEL, Switzerland, Dec. 13, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a world-class…

Click here to view original post

Advertisement — Advertise with Biotech Networks